Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.86 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.86 |
| ▸ | LMNA | P02545 | 2/20 | 0.86 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.78 |
| ▸ | PGR | P06401 | 1/20 | 0.78 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.74 |
| ▸ | PKM | P14618 | 4/20 | 0.73 |
| ▸ | MAPT | P10636 | 4/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.71 |
| ▸ | MEN1 | O00255 | 2/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.71 |
| ▸ | BLM | P54132 | 1/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | GFER | P55789 | 1/20 | 0.71 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | HTT | P42858 | 1/20 | 0.69 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.69 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.69 |
| ▸ | PLAU | P00749 | 1/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32679643 | 0.94 | GAA (0.78) | GAAMAPK1LMNAALDH1A1PGR | |
| SCHEMBL30434229 | 0.93 | GAA (0.76) | GAAMAPK1LMNAALDH1A1PGR | |
| SCHEMBL806437 | 0.93 | GAA (0.76) | GAAMAPK1LMNAALDH1A1PGR | |
| SCHEMBL7564170 | 0.93 | GAA (0.76) | GAAMAPK1LMNAALDH1A1PGR | |
| SCHEMBL29031235 | 0.93 | PGR (0.85) | GAAMAPK1LMNAALDH1A1PGR | |
| SCHEMBL6301477 | 0.91 | GAA (0.73) | GAAMAPK1LMNAALDH1A1PGR | |
| SCHEMBL2240982 | 0.91 | LMNA (0.73) | GAAMAPK1LMNAALDH1A1PGR | |
| SCHEMBL16116950 | 0.91 | GAA (0.73) | GAAMAPK1LMNAALDH1A1PGR | |
| SCHEMBL789993 | 0.91 | PPIA (0.79) | GAAMAPK1LMNAALDH1A1PGR | |
| SCHEMBL8752410 | 0.91 | GAA (0.73) | GAAMAPK1LMNAALDH1A1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0610653-B1 | Thermosensitive recording material | NEW OJI PAPER CO LTD (JP) | 1997-04-16 | — | — | EP | claimed |
| US-5444036-A | Arylsulfonylureido compound, acetoacetanilide compound, sulfonamide derivative; storage stability | NEW OIL PAPER CO., LTD. (JP) | 1995-08-22 | — | — | US | claimed |
| EP-0610653-A1 | Thermosensitive recording material | NEW OJI PAPER CO., LTD. (JP) | 1994-08-17 | — | — | EP | claimed |
| EP-3131658-B1 | IMPROVED SULFUR RECOVERY PROCESS FOR TREATING LOW TO MEDIUM MOLE PERCENT HYDROGEN SULFIDE GAS FEEDS WITH BTEX IN A CLAUS UNIT | SAUDI ARABIAN OIL CO (SA) | 2019-09-25 | — | — | EP | disclosed |
| US-9981848-B2 | Sulfur recovery process for treating low to medium mole percent hydrogen sulfide gas feeds with BTEX in a claus unit | SAUDI ARABIAN OIL COMPANY (SA) | 2018-05-29 | — | — | US | disclosed |
| US-20170137288-A1 | SULFUR RECOVERY PROCESS FOR TREATING LOW TO MEDIUM MOLE PERCENT HYDROGEN SULFIDE GAS FEEDS WITH BTEX IN A CLAUS UNIT | SAUDI ARABIAN OIL COMPANY (SA) | 2017-05-18 | — | — | US | disclosed |
| US-9593015-B2 | Sulfur recovery process for treating low to medium mole percent hydrogen sulfide gas feeds with BTEX in a Claus unit | SAUDI ARABIAN OIL COMPANY (SA) | 2017-03-14 | — | — | US | disclosed |
| EP-3131658-A1 | IMPROVED SULFUR RECOVERY PROCESS FOR TREATING LOW TO MEDIUM MOLE PERCENT HYDROGEN SULFIDE GAS FEEDS WITH BTEX IN A CLAUS UNIT | Saudi Arabian Oil Company (SA) | 2017-02-22 | — | — | EP | disclosed |
| US-9212134-B2 | Inhibitors of viral entry into mammalian cells | MICROBIOTIX, INC. (US) | 2015-12-15 | — | — | US | disclosed |
| US-9212134-B2 | Inhibitors of viral entry into mammalian cells | MICROBIOTIX, INC. (US) | 2015-12-15 | — | — | US | disclosed |
| WO-2015160645-A1 | IMPROVED SULFUR RECOVERY PROCESS FOR TREATING LOW TO MEDIUM MOLE PERCENT HYDROGEN SULFIDE GAS FEEDS WITH BTEX IN A CLAUS UNIT | SAUDI ARABIAN OIL COMPANY (SA) | 2015-10-22 | — | — | WO | disclosed |
| WO-2006028529-A2 | IONIC POLYMER MEMBRANES | BP CORPORATION NORTH AMERICA INC. (US) | 2006-03-16 | — | — | WO | disclosed |
| US-20060049102-A1 | Ionic polymer membranes | BP CORPORATION NORTH AMERICA INC. | 2006-03-09 | — | — | US | disclosed |
| US-20030191309-A1 | N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of C-proteinase and for treating or preventing disorders related to unregulated collagen production | HO WEN-BIN (US) | 2003-10-09 | — | — | US | disclosed |
| US-6579343-B2 | Contacting gas with a liquid ionic compound comprising a nitrogen-containing heterocyclic cation | UNIVERSITY OF NOTRE DAME DU LAC | 2003-06-17 | — | — | US | disclosed |
| US-6506936-B1 | Treating fibrotic disorder selected from hepatic cirrhosis and arthritis; inhibiting matrix metalloproteases | FIBROGEN, INC. | 2003-01-14 | — | — | US | disclosed |
| US-20020189444-A1 | Purification of gas with liquid ionic compounds | NATIONAL SCIENCE FOUNDATION | 2002-12-19 | — | — | US | disclosed |
| EP-0610653-B1 | Thermosensitive recording material | NEW OJI PAPER CO LTD (JP) | 1997-04-16 | — | — | EP | disclosed |
| US-5444036-A | Arylsulfonylureido compound, acetoacetanilide compound, sulfonamide derivative; storage stability | NEW OIL PAPER CO., LTD. (JP) | 1995-08-22 | — | — | US | disclosed |
| EP-0610653-A1 | Thermosensitive recording material | NEW OJI PAPER CO., LTD. (JP) | 1994-08-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030191309-A1 | N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of C-proteinase and for treating or preventing disorders related to unregulated collagen production | MMP1, MMP13, COL14A1 | GAA 417/4885MAPK1 2792/4885LMNA 779/4885 |
| US-20170137288-A1 | SULFUR RECOVERY PROCESS FOR TREATING LOW TO MEDIUM MOLE PERCENT HYDROGEN SULFIDE GAS FEEDS WITH BTEX IN A CLAUS UNIT | MST1, MSTN, TST | GAA 3813/4885MAPK1 1474/4885LMNA 4370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.